PolyPid PYPD
NASDAQ PYPD
$5.08 +0.07 (+1.40%)
At close: Aug 20, 2026 · 4:00 PM EDT

PolyPid (PYPD) Shares Outstanding (2019 - 2026)

PolyPid (PYPD) posted Shares Outstanding (Entity) of $21.9 million for Q1 2026, up 20.44% sequentially from $18.2 million in Q4 2025, and up 115.13% YoY from $10.2 million in Q1 2025.

PolyPid (PYPD) Shares Outstanding (2019 - 2026) Analysis & Trends

PolyPid has reported Shares Outstanding (Entity) for 8 years, with the latest figure at $21.9 million in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 115.13% year-over-year to $21.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.9 million (up 115.13% YoY) and the FY2025 annual result came in at $18.2 million, up 207.87% from the prior year.
  • Shares Outstanding (Entity) climbed to $21.9 million in Q1 2026 per PYPD's latest filing, from $18.2 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $21.9 million in Q1 2026 and troughed at $648960.0 in Q1 2022.
  • A 5-year average of $6.7 million and a median of $4.8 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) rose 3.87% in 2022, then jumped 569.56% in 2024.
  • Over 5 years, Shares Outstanding (Entity) stood at $661662.0 in 2022, then soared by 149.91% to $1.7 million in 2023, then soared by 257.59% to $5.9 million in 2024, then soared by 207.87% to $18.2 million in 2025, then rose by 20.44% to $21.9 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $21.9 million, $18.2 million, and $20.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 62.19 Mn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 111.58 Mn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 133.61 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 217.35 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 445.06 Mn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 241.70 Mn
10 PolyPid 113.30 Mn 106.53 Mn - 22.28 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 21.92 Mn
Mar 31, 2026 21.92 Mn
Dec 31, 2025 16.35 Mn
Sep 30, 2025 20.05 Mn
Jun 30, 2025 12.84 Mn
Mar 31, 2025 11.75 Mn
Dec 31, 2024 5.91 Mn
Sep 30, 2024 6.36 Mn
Jun 30, 2024 5.02 Mn
Mar 31, 2024 4.69 Mn
Dec 31, 2023 1.40 Mn
Sep 30, 2023 1.65 Mn
Jun 30, 2023 1.48 Mn
Mar 31, 2023 716,483.00
Dec 31, 2022 647,492.00
Sep 30, 2022 653,175.00
Jun 30, 2022 650,110.00
Mar 31, 2022 631,152.00
Dec 31, 2021 623,989.00
Sep 30, 2021 625,156.00